159 related articles for article (PubMed ID: 26657287)
1. SLC7A5 act as a potential leukemic transformation target gene in myelodysplastic syndrome.
Ma Y; Song J; Chen B; Xu X; Lin G
Oncotarget; 2016 Feb; 7(6):6566-75. PubMed ID: 26657287
[TBL] [Abstract][Full Text] [Related]
2. miR-378 inhibits cell growth and enhances apoptosis in human myelodysplastic syndromes.
Kuang X; Wei C; Zhang T; Yang Z; Chi J; Wang L
Int J Oncol; 2016 Nov; 49(5):1921-1930. PubMed ID: 27633496
[TBL] [Abstract][Full Text] [Related]
3. [The expression of beta-tubulin gene in myelodysplastic syndrome evoluting to leukemia].
Ma Y; Chen BB; Xu XP; Lin GW
Zhonghua Nei Ke Za Zhi; 2016 May; 55(5):377-80. PubMed ID: 27143188
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of apoptosis by BCL2 prevents leukemic transformation of a murine myelodysplastic syndrome.
Slape CI; Saw J; Jowett JB; Aplan PD; Strasser A; Jane SM; Curtis DJ
Blood; 2012 Sep; 120(12):2475-83. PubMed ID: 22855610
[TBL] [Abstract][Full Text] [Related]
5. Genomic loss of EZH2 leads to epigenetic modifications and overexpression of the HOX gene clusters in myelodysplastic syndrome.
Xu F; Liu L; Chang CK; He Q; Wu LY; Zhang Z; Shi WH; Guo J; Zhu Y; Zhao YS; Gu SC; Fei CM; Li X
Oncotarget; 2016 Feb; 7(7):8119-30. PubMed ID: 26812882
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia.
Liao R; Xu Y; Chen M; Chen X; Zhan X; Sun J
Hematology; 2013 Jul; 18(4):191-7. PubMed ID: 23321417
[TBL] [Abstract][Full Text] [Related]
7. Ribosomal protein S14 silencing inhibits growth of acute myeloid leukemia transformed from myelodysplastic syndromes via activating p53.
Wang L; Luo J; Nian Q; Xiao Q; Yang Z; Liu L
Hematology; 2014 Jun; 19(4):225-31. PubMed ID: 24074450
[TBL] [Abstract][Full Text] [Related]
8. Atg3 Overexpression Enhances Bortezomib-Induced Cell Death in SKM-1 Cell.
Zhuang L; Ma Y; Wang Q; Zhang J; Zhu C; Zhang L; Xu X
PLoS One; 2016; 11(7):e0158761. PubMed ID: 27391105
[TBL] [Abstract][Full Text] [Related]
9. Deregulated microRNA expression and its pathogenetic implications for myelodysplastic syndromes.
Kuang X; Chi J; Wang L
Hematology; 2016 Dec; 21(10):593-602. PubMed ID: 27357100
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of
Jiang M; Chen Y; Deng L; Luo X; Wang L; Liu L
DNA Cell Biol; 2019 May; 38(5):476-484. PubMed ID: 30835546
[TBL] [Abstract][Full Text] [Related]
11. The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation.
Song SJ; Ito K; Ala U; Kats L; Webster K; Sun SM; Jongen-Lavrencic M; Manova-Todorova K; Teruya-Feldstein J; Avigan DE; Delwel R; Pandolfi PP
Cell Stem Cell; 2013 Jul; 13(1):87-101. PubMed ID: 23827711
[TBL] [Abstract][Full Text] [Related]
12. Lenalidomide induces cell death in an MDS-derived cell line with deletion of chromosome 5q by inhibition of cytokinesis.
Matsuoka A; Tochigi A; Kishimoto M; Nakahara T; Kondo T; Tsujioka T; Tasaka T; Tohyama Y; Tohyama K
Leukemia; 2010 Apr; 24(4):748-55. PubMed ID: 20130600
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic microRNAs in myelodysplastic syndrome.
Erdogan B; Facey C; Qualtieri J; Tedesco J; Rinker E; Isett RB; Tobias J; Baldwin DA; Thompson JE; Carroll M; Kim AS
Exp Hematol; 2011 Sep; 39(9):915-926.e2. PubMed ID: 21703983
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations.
Aslan D; Garde C; Nygaard MK; Helbo AS; Dimopoulos K; Hansen JW; Severinsen MT; Treppendahl MB; Sjø LD; Grønbæk K; Kristensen LS
Oncotarget; 2016 Mar; 7(9):9951-63. PubMed ID: 26848861
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol Suppresses Growth and Migration of Myelodysplastic Cells by Inhibiting the Expression of Elevated Cyclin D1 (CCND1).
Zhou W; Xu S; Ying Y; Zhou R; Chen X
DNA Cell Biol; 2017 Nov; 36(11):966-975. PubMed ID: 29035583
[TBL] [Abstract][Full Text] [Related]
16. SPARC silencing inhibits the growth of acute myeloid leukemia transformed from myelodysplastic syndrome via induction of cell cycle arrest and apoptosis.
Nian Q; Xiao Q; Wang L; Luo J; Chen LP; Yang ZS; Liu L
Int J Mol Med; 2014 Apr; 33(4):856-62. PubMed ID: 24535175
[TBL] [Abstract][Full Text] [Related]
17. Telomere length, c-myc and mad-1 expression could represent prognosis markers of myelodysplastic syndrome.
Poloni A; Serrani F; Berardinelli E; Maurizi G; Mariani M; Costantini B; Trappolini S; Mancini S; Olivieri A; Leoni P
Leuk Res; 2013 Nov; 37(11):1538-44. PubMed ID: 24095110
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of HERG K
Lu L; Du W; Liu W; Guo D; He X; Li H
Hematology; 2016 Dec; 21(10):583-592. PubMed ID: 27077769
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of miR-196b-5p is significantly associated with the progression of myelodysplastic syndrome.
Wen J; Huang Y; Li H; Zhang X; Cheng P; Deng D; Peng Z; Luo J; Zhao W; Lai Y; Liu Z
Int J Hematol; 2017 Jun; 105(6):777-783. PubMed ID: 28224273
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of BMI1 confers clonal cells resistance to apoptosis and contributes to adverse prognosis in myelodysplastic syndrome.
Xu F; Yang R; Wu L; He Q; Zhang Z; Zhang Q; Yang Y; Guo J; Chang C; Li X
Cancer Lett; 2012 Apr; 317(1):33-40. PubMed ID: 22120066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
